Completed Diabetes, Hormones & Metabolism

Glucowear: A non-invasive, wearable, real time continuous blood glucose monitoring sensor

In plain English

AI plain-English summary

A watch strap sensor measures blood glucose by detecting shifts in radio-wave frequency, without piercing the skin. This matters because millions of people with diabetes currently rely on finger-prick tests or invasive continuous monitors with needles that must be replaced every few days. The Glucowear sensor aims to eliminate both the pain and the waste. It fits on the underside of a standard watch strap, connects via Bluetooth to a phone or smartwatch, and sends real-time alerts to the user—and, if needed, to a physician or carer. A proof-of-concept clinical trial in 2020 showed glucose tracking comparable to the market leader. The device is now at technology readiness level 6, with a wearable prototype undergoing in-house developmental testing. Battery life is 10–14 days; shelf life is at least two years. If successful, this could shift diabetes management from a daily chore of pricks and sensor replacements to a passive, continuous process that integrates into ordinary life. It would also reduce medical waste from disposable sensor components. The personalised algorithm, trained on each user’s first day of data, adapts to individual physiology rather than applying a one-size-fits-all correction.

View original technical description
A non-invasive, real-time BG sensor, utilising shifts in radio-wave frequency that correlate to changes in BG concentration, with a personalised algorithm for each individual trained using day 1 data. The device will be a wearable sensor designed to fit on the underside of a watch strap and compatible with iOS, android smart watches and phones. The sensor will take real time measurements, connected via Bluetooth to a phone/watch where the app will provide alerts to the user and if required, physicians/carers in real time. Battery life of 10-14 days and shelf life of at least 2 years. POC clinical trial completed in 2020, results show tracking of BG comparable to the market leader and included algorithm training. Device is now at TRL6, with components integrated into ‘first-pass’ of wearable design and in-house developmental testing conducted, including subjects tested in non-clinical environments and further algorithm building. V3 is in development. Robust patent portfolio.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

A compact portable non-invasive glucose sensor
Skin-Agnostic Non-Invasive Blood Glucose Monitoring
Non-invasive glucose monitoring using high-frequency radio waves
First wearable sensor for real-time monitoring and optimisation of sport training
Cardiff University and Gluco RX Limited KTP 22_23 R1

Original classification

EU-Funded

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.